Arcturus Therapeutics Holdings Inc.
ARCT
$10.53
$0.232.23%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -80.94M | -62.64M | -71.96M | -107.30M | -29.73M |
| Total Depreciation and Amortization | 3.54M | 3.54M | 3.46M | 3.28M | 2.96M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 38.46M | 38.46M | 37.97M | 36.54M | 1.29M |
| Change in Net Operating Assets | -20.81M | -39.45M | -38.19M | 79.69M | 7.38M |
| Cash from Operations | -59.75M | -60.09M | -68.73M | 12.22M | -18.10M |
| Capital Expenditure | -648.00K | -1.52M | -2.42M | -2.45M | -2.90M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -648.00K | -1.52M | -2.42M | -2.45M | -2.90M |
| Total Debt Issued | -- | 0.00 | 20.00M | 20.00M | 20.00M |
| Total Debt Repaid | -- | -20.00M | -20.00M | -20.00M | -47.36M |
| Issuance of Common Stock | 5.42M | 6.63M | 7.77M | 5.47M | 3.28M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 5.42M | -13.37M | 7.77M | 5.47M | -24.09M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -54.98M | -74.99M | -63.38M | 15.23M | -45.09M |